April 20, 2022 – San Francisco sued Endo, Teva Pharmaceutical Industries Ltd and Allergan Plc, drug distributor Anda Inc, pharmacy Walgreens Boots Alliance Inc in 2018. The companies created a “public nuisance” by flooding the city with prescription opioids and failing to prevent the drugs from being diverted for illegal use, according to the lawsuit.
The companies have denied the allegations, and a trial against the remaining defendants is scheduled to kick off on April 25 in California federal court.
When it was filed, the lawsuit also targeted Purdue Pharma LP, Johnson & Johnson, McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp, but the city previously settled with those defendants.
Chiu said at a Wednesday press conference that the upcoming trial would be the first to test claims against “each part of the opioid supply chain.”
Since 2019, Endo has agreed to make $300 million in opioid settlement payments with state and local governments, including the San Francisco settlement. The largest to date are a $65 million settlement with Florida and a $63 million settlement with Texas.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…